WallStreetZenWallStreetZen

NASDAQ: IRMD
Iradimed Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IRMD stock forecasts and price targets.

Forecast return on equity

Is IRMD forecast to generate an efficient return?

Company
27.84%
Industry
20.84%
Market
341.7%
IRMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IRMD forecast to generate an efficient return on assets?

Company
23.87%
Industry
11.71%
IRMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IRMD earnings per share forecast

What is IRMD's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$1.90+13.91%
Avg 2 year Forecast
$2.16+29.49%
Avg 3 year Forecast
$2.15+28.87%
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

IRMD revenue forecast

What is IRMD's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$84.4M+4.77%
Avg 2 year Forecast
$92.9M+15.4%
Avg 3 year Forecast
$96.4M+19.7%
IRMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IRMD earnings growth forecast

How is IRMD forecast to perform vs Medical Devices companies and vs the US market?

Company
11.52%
Industry
16.95%
Market
105.36%
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
IRMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

IRMD revenue growth forecast

How is IRMD forecast to perform vs Medical Devices companies and vs the US market?

Company
6.49%
Industry
7.58%
Market
58.13%
IRMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IRMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IRMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
IRMD$94.02N/AN/A
CNMD$39.80$51.50+29.40%Buy
SSII$5.87N/AN/A
BBNX$29.19$29.00-0.65%Strong Buy
IART$13.04$13.00-0.31%Sell
View Top Medical Device Stocks

Iradimed Stock Forecast FAQ

What is IRMD's earnings growth forecast for 2025-2027?

(NASDAQ: IRMD) Iradimed's forecast annual earnings growth rate of 11.52% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 16.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.36%.

Iradimed's earnings in 2025 is $21,184,820.On average, 4 Wall Street analysts forecast IRMD's earnings for 2025 to be $24,199,455, with the lowest IRMD earnings forecast at $23,188,123, and the highest IRMD earnings forecast at $24,977,990. On average, 4 Wall Street analysts forecast IRMD's earnings for 2026 to be $27,508,228, with the lowest IRMD earnings forecast at $26,429,474, and the highest IRMD earnings forecast at $28,317,293.

In 2027, IRMD is forecast to generate $27,378,472 in earnings, with the lowest earnings forecast at $26,304,806 and the highest earnings forecast at $28,183,721.

If you're new to stock investing, here's how to buy Iradimed stock.

What is IRMD's revenue growth forecast for 2025-2027?

(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 6.49% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.13%.

Iradimed's revenue in 2025 is $80,511,268.On average, 4 Wall Street analysts forecast IRMD's revenue for 2025 to be $1,073,080,393, with the lowest IRMD revenue forecast at $1,028,505,463, and the highest IRMD revenue forecast at $1,107,313,024. On average, 4 Wall Street analysts forecast IRMD's revenue for 2026 to be $1,181,948,046, with the lowest IRMD revenue forecast at $1,134,218,269, and the highest IRMD revenue forecast at $1,218,177,899.

In 2027, IRMD is forecast to generate $1,225,912,361 in revenue, with the lowest revenue forecast at $1,177,826,392 and the highest revenue forecast at $1,261,964,118.

What is IRMD's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: IRMD) forecast ROA is 23.87%, which is higher than the forecast US Medical Devices industry average of 11.71%.

What is IRMD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IRMD) Iradimed's current Earnings Per Share (EPS) is $1.67. On average, analysts forecast that IRMD's EPS will be $1.90 for 2025, with the lowest EPS forecast at $1.82, and the highest EPS forecast at $1.96. On average, analysts forecast that IRMD's EPS will be $2.16 for 2026, with the lowest EPS forecast at $2.08, and the highest EPS forecast at $2.23. In 2027, IRMD's EPS is forecast to hit $2.15 (min: $2.07, max: $2.22).

What is IRMD's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: IRMD) forecast ROE is 27.84%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.